Information Library
Results for: Oncology - Regulatory & Quality
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Turkey Oncology Capabilities
Brochure — February 6, 2012
Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment. -
Middle East Oncology capabilities
Brochure — February 6, 2012
Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates. -
The Evolution of Oncologic Drug Development
Hear from the Experts — July 8, 2010
Despite a doubling in the number of candidates in the cancer drug pipeline from 1990 through 2006, the overall US approval rate for cancer drugs -
Sub-Saharan Africa Phase II/III Fact Sheet
Brochure — July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
Page 1 of 1 (4 results)
